• Accessibility statement
  • Homepage
  • Sitemap
  • Search
  • Contact
  • Print
Boehringer-Ingelheim Logo
Value through Innovation

Help

jump to main navigationjump to content
  • Home
  • Contact
  • Site Map

main navigation

jump to contentto meta navigation
  • News Centre
  • Corporate Profile
  • Corporate Responsibility
  • Global Activities
  • Research & Development
  • Clinical Trials
  • Contract Manufacturing
  • Partnering
  • Products
  • Careers
Successfully taking new paths - into the future with a spirit of research

page content

jump to main navigationto meta navigation

Oncology and white room

No flash player detected. For optimized usage of this website your browser should support shockwave flash. For downloading see Macromedia Flash Player
  • Discover oncology website
  • Discover the white room

Our Global Activities

  • Our Countries A-Z
  • Albania
  • Argentina
  • Armenia
  • Austria
  • Australia
  • Azerbaijan
  • Bahrain
  • Belarus
  • Belgium
  • Bosnia and Herzegovina
  • Brazil
  • Bulgaria
  • Canada
  • Chile
  • China
  • Colombia
  • Croatia
  • Cyprus
  • Czech Republic
  • Denmark
  • Ecuador
  • Egypt
  • Estonia
  • Ethiopia
  • Finland
  • France
  • Georgia
  • Germany
  • Germany Headquarters
  • Greece
  • Ghana
  • Hong Kong
  • Hungary
  • India
  • Indonesia
  • Iraq
  • Irland
  • Israel
  • Italy
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kirghizia
  • Kuweit
  • Latvia
  • Lebanon
  • Libya
  • Lithuania
  • Macedonia
  • Malawi
  • Malaysia
  • Malta
  • Mauritius
  • Mexico
  • Moldavia
  • Mongolia
  • Montenegro
  • The Netherlands
  • New Zealand
  • Nigeria
  • Norway
  • Oman
  • Pakistan
  • Peru
  • The Philippines
  • Poland
  • Portugal
  • Quatar
  • Romania
  • Russia
  • Saudi Arabia
  • Seychelles
  • Serbia
  • Singapore
  • Slovakia
  • Slovenia
  • Somalia
  • South Africa
  • South Korea
  • Spain
  • Sudan
  • Sweden
  • Switzerland
  • Syria
  • Taiwan
  • Tajikistan
  • Tanzania
  • Thailand
  • Turkey
  • Turkmenistan
  • USA
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • Uruguay
  • Uzbekistan
  • Venezuela
  • Vietnam
  • Yemen
for US residents

Latest Press Releases

29.04.2012 Switching to TWYNSTA® allows patients with uncontrolled hypertension on monotherapy to rapidly reach their blood pressure goals -

For Non-US and Non-UK Healthcare Media Only

24.04.2012 Boehringer Ingelheim on growth path - Successful 2011 financial year
20.04.2012 GLORIA TM-AF Registry Program investigating use of antithrombotic therapy in 56,000 patients with atrial fibrillation at risk of stroke announced -

For non-US, UK & Canadian Media

19.04.2012 Viral cure achieved without interferon in up to 82% of hepatitis C patients (GT-1a & -1b*) -

For media outside of the U.S.A. only

19.04.2012 First ever data investigating interferon-free treatment in hepatitis C patients who have liver cirrhosis shows high viral cure rate -

For media outside of the U.S.A. only

Further press releases

Partnership with Ashoka

Making more health
Ashoka/Changemakers

Drug discovery process

From discovery to a marketable drug is a long road, always led by curiosity
See further details

App - Boehringer Ingelheim

Annual report 2011
Free download for ipads
back to top

Further Media Channels

  • Mobile Devices
  • RSS Feed
  • Follow us on Facebook
  • Follow us on Twitter
  • Follow us on YouTube
  • Follow us on flickr

Top Links

Take-away-info Annual report Financial highlights Licensing & Partnering Careers - experienced Indication areas Stroke Prevention Consumer Health Care Biopharmaceuticals Animal Health Research Areas Contact
© 2010 - 2012 Boehringer Ingelheim GmbH All rights reserved
  • Print Page
  • Recommend
  • Accessibility Statement
  • Terms of use
  • Imprint
  • RSS Feed